Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes

References

• ClinicalTrialsgov [homepage on the Internet]Bethesda, MDNational Library of Medicine (US) Available from: http://clinicaltrials.gov/ct2/homeAccessed Nov 2, 2011
   Google Scholar
• HatcherHPlanalpRChoJTortiFMTortiSVCurcumin: from ancient medicine to current clinical trialsCell Mol Life Sci200865111631165218324353
   PubMed Web of Science ®Google Scholar
• Bar-SelaGEpelbaumRSchafferMCurcumin as an anti-cancer agent: review of the gap between basic and clinical applicationsCurr Med Chem201017319019720214562
   PubMed Web of Science ®Google Scholar
• MaheshwariRKSinghAKGaddipatiJSrimalRCMultiple biological activities of curcumin: a short reviewLife Sci200678182081208716413584
   PubMed Web of Science ®Google Scholar
• AbuzeidWMDavisSTangALSensitization of head and neck cancer to cisplatin through the use of a novel curcumin analogArch Otolaryngol Head Neck Surg2011137549950721576562
   PubMedGoogle Scholar
• BavaSVPuliappadambaVTDeeptiANairAKarunagaranDAntoRJSensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerizationJ Biol Chem200528086301630815590651
   PubMed Web of Science ®Google Scholar
• ChanMMFongDSopranoKJHolmesWFHeverlingHInhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agentsJ Cell Physiol20031941637012447990
   PubMed Web of Science ®Google Scholar
• ChatterjeeSJPandeySChemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagyCancer Biol Ther201111221622821088500
   PubMed Web of Science ®Google Scholar
• DeebDDJiangHGaoXDivineGDulchavskySAGautamSCChemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosisJ Exp Ther Oncol200552819116471035
   PubMedGoogle Scholar
• YallapuMMMaherDMSundramVBellMCJaggiMChauhanSCCurcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growthJ Ovarian Res201031120429876
   PubMed Web of Science ®Google Scholar
• AnandPThomasSGKunnumakkaraABBiological activities of curcumin and its analogues (Congeners) made by man and Mother NatureBiochem Pharmacol200876111590161118775680
   PubMed Web of Science ®Google Scholar
• BansalSSGoelMAqilFVadhanamMVGuptaRCAdvanced drug delivery systems of curcumin for cancer chemopreventionCancer Prev Res (Phila)2011481158117121546540
   PubMed Web of Science ®Google Scholar
• BishtSMaitraASystemic delivery of curcumin: 21st century solutions for an ancient conundrumCurr Drug Discov Technol20096319219919496751
   PubMedGoogle Scholar
• AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
   PubMed Web of Science ®Google Scholar
• KurienBTScofieldRHIncreasing aqueous solubility of curcumin for improving bioavailabilityTrends Pharmacol Sci200930733433519523694
   PubMed Web of Science ®Google Scholar
• AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Pharmacol201079333033819735646
   PubMed Web of Science ®Google Scholar
• AntonyBMerinaBIyerVSJudyNLennertzKJoyalSA Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM- 95CG (Biocurcumax), A Novel Bioenhanced Preparation of CurcuminIndian J Pharm Sci200870444544920046768
   PubMed Web of Science ®Google Scholar
• BegumANJonesMRLimGPCurcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s diseaseJ Pharmacol Exp Ther2008326119620818417733
   PubMed Web of Science ®Google Scholar
• ShaikhJAnkolaDDBeniwalVSinghDKumarMNNanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEur J Pharm Sci2009373–422323019491009
   PubMed Web of Science ®Google Scholar
• YanYDKimJAKwakMKYooBKYongCSChoiHGEnhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying techniqueBiol Pharm Bull20113481179118621804203
   PubMed Web of Science ®Google Scholar
• YallapuMMGuptaBKJaggiMChauhanSCFabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cellsJ Colloid Interface Sci20103511192920627257
   PubMed Web of Science ®Google Scholar
• YallapuMMJaggiMChauhanSCbeta-Cyclodextrin-curcumin self- assembly enhances curcumin delivery in prostate cancer cellsColloids Surf B Biointerfaces201079111312520456930
   PubMed Web of Science ®Google Scholar
• GaoYLiZSunMPreparation and characterization of intravenously injectable curcumin nanosuspensionDrug Deliv201118213114220939679
   PubMed Web of Science ®Google Scholar
• KakkarVSinghSSinglaDKaurIPExploring solid lipid nanoparticles to enhance the oral bioavailability of curcuminMol Nutr Food Res201155349550320938993
   PubMed Web of Science ®Google Scholar
• XieXTaoQZouYPLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and MechanismsJ Agric Food Chem201159179280928921797282
   PubMed Web of Science ®Google Scholar
• YallapuMMDobberpuhlMRMaherDMJaggiMChauhanSCDesign of Curcumin loaded Cellulose Nanoparticles for Prostate CancerCurr drug metab2011 [Epub ahead of print]
   Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
   PubMed Web of Science ®Google Scholar
• LiangXJChenCZhaoYJiaLWangPCBiopharmaceutics and therapeutic potential of engineered nanomaterialsCurr Drug Metab20089869770918855608
   PubMed Web of Science ®Google Scholar
• ZhangJWuLChanHKWatanabeWFormation, characterization, and fate of inhaled drug nanoparticlesAdv Drug Deliv Rev201063644145521118707
   PubMed Web of Science ®Google Scholar
• BalaIHariharanSKumarMNPLGA nanoparticles in drug delivery: the state of the artCrit Rev Ther Drug Carrier Syst200421538742215719481
   PubMed Web of Science ®Google Scholar
• DebbagePTargeted drugs and nanomedicine: present and futureCurr Pharm Des200915215317219149610
   PubMed Web of Science ®Google Scholar
• PaudelKRRauniarGPBhattacharyaSKDasBPRecent advancement in drug delivery systemKathmandu Univ Med J (KUMJ)20086226226718769102
   PubMedGoogle Scholar
• ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
   PubMed Web of Science ®Google Scholar
• ThierryBDrug nanocarriers and functional nanoparticles: applications in cancer therapyCurr Drug Deliv20096439140319534706
   PubMedGoogle Scholar
• XieYBagbyTRCohenMSForrestMLDrug delivery to the lymphatic system: importance in future cancer diagnosis and therapiesExpert Opin Drug Deliv20096878579219563270
   PubMed Web of Science ®Google Scholar
• YallapuMMVasirJKJainTKVijayaraghavaluSLabhasetwarVSynthesis, Characterization and Antiproliferative Activity of Rapamycin- Loaded Poly (N-Isopropylacrylamide)-Based Nanogels in Vascular Smooth Muscle CellsJ Biomed Nanotechnol200841624
   Web of Science ®Google Scholar
• PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
   PubMed Web of Science ®Google Scholar
• VasirJKLabhasetwarVBiodegradable nanoparticles for cytosolic delivery of therapeuticsAdv Drug Deliv Rev200759871872817683826
   PubMed Web of Science ®Google Scholar
• ZhangJWuLChanHKWatanabeWFormation, characterization, and fate of inhaled drug nanoparticlesAdv Drug Deliv Rev201163644145521118707
   PubMed Web of Science ®Google Scholar
• EmerichDFThanosCGTargeted nanoparticle-based drug delivery and diagnosisJ Drug Target200715316318317454354
   PubMed Web of Science ®Google Scholar
• ShekunovBNanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies – part IIIDrugs20058540240315883922
   PubMed Web of Science ®Google Scholar
• SinghRLillardJWJrNanoparticle-based targeted drug deliveryExp Mol Pathol200986321522319186176
   PubMed Web of Science ®Google Scholar
• MukerjeeAVishwanathaJKFormulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapyAnticancer Res200929103867387519846921
   PubMed Web of Science ®Google Scholar
• PrajaktaDRatneshJChandanKCurcumin loaded pH-sensitive nanoparticles for the treatment of colon cancerJ Biomed Nanotechnol20095544545520201417
   PubMed Web of Science ®Google Scholar
• SouKOyajobiBGoinsBPhillipsWTTsuchidaECharacterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol)J Biomed Nanotechnol20095220220820055098
   PubMed Web of Science ®Google Scholar
• LynchICedervallTLundqvistMCabaleiro-LagoCLinseSDawsonKAThe nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st centuryAdv Colloid Interface Sci2007134–135167174
   PubMed Web of Science ®Google Scholar
• EhrenbergMSFriedmanAEFinkelsteinJNOberdorsterGMcGrathJLThe influence of protein adsorption on nanoparticle association with cultured endothelial cellsBiomaterials200930460361019012960
   PubMed Web of Science ®Google Scholar
• HorieMNishioKFujitaKProtein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cellsChem Res Toxicol200922354355319216582
   PubMed Web of Science ®Google Scholar
• KastantinMMissirlisDBlackMAnanthanarayananBPetersDTirrellMThermodynamic and kinetic stability of DSPE-PEG(2000) micelles in the presence of bovine serum albuminJ Phys Chem B201011439126321264020828210
   PubMed Web of Science ®Google Scholar
• LacerdaSHParkJJMeuseCInteraction of gold nanoparticles with common human blood proteinsACS Nano20104136537920020753
   PubMed Web of Science ®Google Scholar
• MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201013382525253421288025
   PubMed Web of Science ®Google Scholar
• YallapuMMFoySPJainTKLabhasetwarVPEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applicationsPharm Res201027112283229520845067
   PubMed Web of Science ®Google Scholar
• BihariPVippolaMSchultesSOptimized dispersion of nanoparticles for biological in vitro and in vivo studiesPart Fibre Toxicol200851418990217
   PubMed Web of Science ®Google Scholar
• ZhangXYinLTangMPuYOptimized method for preparation of TiO2 nanoparticles dispersion for biological studyJ Nanosci Nanotechnol20101085213521921125873
   PubMed Web of Science ®Google Scholar
• RusoJMTaboadaPVarelaLMAttwoodDMosqueraVAdsorption of an amphiphilic penicillin onto human serum albumin: characterisation of the complexBiophys Chem2001921–214115311527586
   PubMed Web of Science ®Google Scholar
• AlmeidaJPChenALFosterADrezekRIn vivo biodistribution of nanoparticlesNanomedicine (Lond)20116581583521793674
   PubMed Web of Science ®Google Scholar
• JokerstJVLobovkinaTZareRNGambhirSSNanoparticle PEGylation for imaging and therapyNanomedicine (Lond)20116471572821718180
   PubMed Web of Science ®Google Scholar
• SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine20106566267120230912
   PubMed Web of Science ®Google Scholar
• ChambersEMitragotriSLong circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulationExp Biol Med (Maywood)2007232795896617609513
   PubMed Web of Science ®Google Scholar
• CiochinaADBredeteanODimitriuDCIacobGConsiderations on in vitro and in vivo magnetic nanoparticles hemocompatibility testingRev Med Chir Soc Med Nat Iasi2009113127928521495331
   PubMedGoogle Scholar
• KoziaraJMOhJJAkersWSFerrarisSPMumperRJBlood compatibility of cetyl alcohol/polysorbate-based nanoparticlesPharm Res200522111821182816132346
   PubMed Web of Science ®Google Scholar
• MayerAVadonMRinnerBNovakAWintersteigerRFrohlichEThe role of nanoparticle size in hemocompatibilityToxicology20092582–313914719428933
   PubMed Web of Science ®Google Scholar
• ShelmaRSharmaCPDevelopment of lauroyl sulfated chitosan for enhancing hemocompatibility of chitosanColloids Surf B Biointerfaces201184256157021367586
   PubMed Web of Science ®Google Scholar
• FischerHCChanWCNanotoxicity: the growing need for in vivo studyCurr Opin Biotechnol200718656557118160274
   PubMed Web of Science ®Google Scholar
• GraingerDWNanotoxicity assessment: all small talk?Adv Drug Deliv Rev200961641942119386273
   PubMed Web of Science ®Google Scholar
• FischerDLiYAhlemeyerBKrieglsteinJKisselTIn vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysisBiomaterials20032471121113112527253
   PubMed Web of Science ®Google Scholar
• WangWXiongWZhuYXuHYangXProtective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cellsJ Biomed Mater Res B Appl Biomater2010931596420186802
   PubMed Web of Science ®Google Scholar
• SutherlandEDixonBSLeffertHLSkallyHZaccaroLSimonFRBiochemical localization of hepatic surface-membrane Na+,K+-ATPase activity depends on membrane lipid fluidityProc Natl Acad Sci U S A19888522867386772847169
   PubMed Web of Science ®Google Scholar
• ChenCHZuklieBMRothLGElucidation of biphasic alterations on acetylcholinesterase (AChE) activity and membrane fluidity in the structure-functional effects of tetracaine on AChE-associated membrane vesiclesArch Biochem Biophys199835111351409500847
   PubMed Web of Science ®Google Scholar
• KlajnertBSadowskaMBryszewskaMThe effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activityBioelectrochemistry2004651232615522688
   PubMed Web of Science ®Google Scholar
• CiolkowskiMRozanekMSzewczykMKlajnertBBryszewskaMThe influence of PAMAM-OH dendrimers on the activity of human erythrocytes ATPasesBiochim Biophys Acta20111808112714272321806962
   PubMed Web of Science ®Google Scholar
• BishtSMizumaMFeldmannGSystemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancerMol Cancer Ther2010982255226420647339
   PubMed Web of Science ®Google Scholar
• LimKJBishtSBarEEMaitraAEberhartCGA polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumorsCancer Biol Ther201111546447321193839
   PubMed Web of Science ®Google Scholar